Malaria: Clinical Trials

11 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 unknown. 11 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Unknown 11
Phase 14Unknown 4
Phase 31Unknown 1

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MSP3-CRM-Vac4All/ Alhydrogel® Vaccine
MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine - Malaria,Falciparum
Phase 1 / Phase 2UnknownVac4All4652023-03-272023-04-26
Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers
Vaccine PvCS N+C+R 150 mcg, Placebo SSN Montanide ISA-51 1 mL - Malaria, Vivax
Phase 2UnknownMalaria Vaccine and Drug Development Center1202021-06-012021-03-01
Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections
Pyronaridine tetraphosphate 180mg:artesunate 60mg - Malaria,Falciparum
Phase 2UnknownShin Poong Pharmaceutical Co. Ltd.3002018-10-032019-09-30
Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites
Imatinib, Dihydroartemisinin-piperaquine - Plasmodium Falciparum Malaria (Drug Resistant)
Phase 2UnknownNurex S.r.l.502017-09-172018-10-05
Plasmodium Immunotherapy for Lung Cancer
Blood-stage infection of P. vivax - Lung Cancer, Nonsmall Cell
Phase 1 / Phase 2UnknownState Key Laboratory of Respiratory Disease302016-06-272023-06-22
Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage)
Lyophilised PEBS synthetic protein (PfPEBS), Rehydragel™ HPA - Malaria
Phase 1 / Phase 2UnknownVac4All362012-05-012012-05-25
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Fosmidomycin and clindamycin - Malaria
Phase 2UnknownZentopharm GmbH1002011-06-012011-05-26
Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults
Fosmidomycin, Azithromycin - Malaria
Phase 2UnknownJomaa Pharma GmbH432008-11-012011-11-03
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
MSP3 Long Synthetic Peptide 30 micrograms of MSP3 LSP, Verorab vaccine - Malaria
Phase 2UnknownAfrican Malaria Network Trust3782008-05-012008-05-07
Randomized Trial of Erythropoietin During Cerebral Malaria
Placebo, Erythropoietin - Cerebral Malaria
Phase 2 / Phase 3UnknownClaude Bernard University1202007-10-012008-06-13
IPTi in Mozambican Infants for Malaria Prevention
Sulfadoxine-Pyrimethamine (Fansidar) - Malaria
Phase 1 / Phase 2UnknownHospital Clinic of Barcelona14982002-09-012006-11-16

Narrower conditions

Malaria, Falciparum (5)  ·  Malaria, Vivax (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Malaria, Cerebral (1)

Broader conditions

Infections (11)  ·  Mosquito-Borne Diseases (11)  ·  Parasitic Diseases (11)  ·  Protozoan Infections (11)  ·  Vector Borne Diseases (11)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Parasitic Infections (1)  ·  Central Nervous System Protozoal Infections (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)

Interventions

fosmidomycin (2)  ·  Aluminum Hydroxide (1)  ·  Artesunate (1)  ·  Azithromycin (1)  ·  Clindamycin (1)  ·  Erythropoietin (1)  ·  Imatinib Mesylate (1)  ·  benzene-1,4-diphosphonic acid (1)  ·  epoetin beta (1)  ·  fanasil, pyrimethamine drug combination (1)  ·  pyronaridine (1)  ·  pyronaridine tetraphosphate, artesunate drug combination (1)

Sponsors

Vac4All (2)  ·  African Malaria Network Trust (1)  ·  Claude Bernard University (1)  ·  Hospital Clinic of Barcelona (1)  ·  Jomaa Pharma GmbH (1)  ·  Malaria Vaccine and Drug Development Center (1)  ·  Nurex S.r.l. (1)  ·  Shin Poong Pharmaceutical Co. Ltd. (1)  ·  State Key Laboratory of Respiratory Disease (1)  ·  Zentopharm GmbH (1)

Countries

Mali (3)  ·  China (1)  ·  Colombia (1)  ·  Gabon (1)  ·  Mozambique (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  The Gambia (1)  ·  Vietnam (1)  ·  Zambia (1)

Top investigators

Clara Menendez, MD, PhD (1)  ·  Francesco M Turrini, MD, PhD (1)  ·  Francois Spertini, MD (1)  ·  Huynh D Chien, MD, PhD (1)  ·  Jang Sik Shin (1)  ·  Mahamadou S Sissoko, MD, MSPH (1)  ·  Manamadou Thera, MD (1)  ·  Ming Ou-Yang, M.D. (1)  ·  Pierre L Druilhe, MD (1)  ·  Roma Chilengi, MBChB, MSc (1)  ·  Saadou Issifou, MD PhD (1)  ·  Srivicha Krudsood, Prof (1)

Results publications

PMID 18419347, PMID 19630971, PMID 21292874, PMID 21931708, PMID 33983371